Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Samsara Inc (IOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Samsara Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while Samsara Inc trades at $40.11 (market cap $23.89B). The key difference: Samsara Inc is far larger — about 3.4× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Samsara Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Samsara Inc for 19 Days on average.
| IONS | IOT | |
|---|---|---|
Market Cap | $7.10B | $23.89B |
Volume | 2,027,457 | 4,063,536 |
Sector | Health | Technology |
52-Week High | $86.50 | $45.22 |
52-Week Low | $42.38 | $24.25 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $6.66B | $23.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IOT (Samsara Inc.) trades at $41.27, down 0.84% on the day, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.20 actual versus $0.16 expected, and achieved 30% year-over-year revenue growth. Analyst consensus is strongly positive with a $51.15 price target. Recent news highlights partnerships and product launches, including the Samsara MCP for AI integration and a rewards program for drivers.
The outlook remains favorable due to robust revenue growth and expanding large-customer adoption, though high valuation multiples (P/E 272, P/S 12.88) pose risks. Key opportunities include AI-driven operational efficiencies and market expansion, while risks involve cash flow pressures and competitive threats. Institutional interest is strong, with the California State Teachers Retirement System increasing its stake significantly in Q2 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Samsara Inc
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →
